Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer.

Date publication

juillet 2024

Journal

EJNMMI research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BRUNOTTE François , Pr COUTANT Charles , Dr LADOIRE Sylvain , Pr COCHET Alexandre , Dr DESMOULINS Isabelle

Tous les auteurs :
Payan N, Presles B, Coutant C, Desmoulins I, Ladoire S, Beltjens F, Brunotte F, Vrigneaud JM, Cochet A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38965124

Résumé

The aim of this study is to investigate the added value of combining tumour blood flow (BF) and metabolism parameters, including texture features, with clinical parameters to predict, at baseline, the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in patients with newly diagnosed breast cancer (BC).

Mots clés

F-FDG PET/CT, Blood flow, Breast cancer, Pathological Response, Texture Features

Référence

EJNMMI Res. 2024 07 4;14(1):60